Psychedelics developer Definium scores more positive data for LSD pill
Results from a late-stage study focused on generalized anxiety disorder were a “clean win” to analysts, who believe Definium has a drug with multibillion-dollar sales potential.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.